Aviva (LON:AV – Get Free Report)‘s stock had its “hold” rating reissued by analysts at Jefferies Financial Group in a report released on Tuesday, Digital Look reports. They currently have a GBX 694 price target on the stock. Jefferies Financial Group’s price target points to a potential downside of 2.06% from the stock’s current price.
Other research analysts have also recently issued reports about the stock. JPMorgan Chase & Co. increased their price target on shares of Aviva from GBX 715 to GBX 800 and gave the company an “overweight” rating in a report on Thursday, August 13th. Citigroup lifted their price target on Aviva from GBX 671 to GBX 721 and gave the company a “neutral” rating in a research note on Wednesday, August 26th. Berenberg Bank reissued a “buy” rating and set a GBX 820 target price on shares of Aviva in a research note on Monday. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a GBX 780 price target on shares of Aviva in a report on Monday, September 7th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Aviva has a consensus rating of “Moderate Buy” and an average target price of GBX 760.71.
Aviva Stock Down 0.6%
Insider Activity at Aviva
In other news, insider Pippa Lambert bought 210 shares of the company’s stock in a transaction dated Tuesday, September 15th. The shares were purchased at an average price of GBX 710 per share, for a total transaction of £1,491. Insiders acquired 484 shares of company stock valued at $348,286 over the last 90 days. Corporate insiders own 0.17% of the company’s stock.
Aviva Company Profile
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products. It also provides insurance cover to individuals, small and medium-sized businesses for risks associated with motor vehicles and medical expenses, as well as property and liability, such as employers' and professional indemnity liabilities.
Further Reading
- Five stocks we like better than Aviva
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.
